Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT1YWO5)

• DTT Name: Glucagon-like peptide 2 receptor (GLP2R) DTT Info
• Gene Name: GLP2R

Molecule-Related Drug & Molecule List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Teduglutide	DMYOAKS	Short bowel syndrome	KB89.1	Approved	[1]

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Elsiglutide	DMB7CPG	Diarrhea	ME05.1	Phase 2	[2]
SAN-134	DMWU71N	Osteoporosis	FB83.0	Phase 1	[3]
ZP-1848	DMGTL8Z	Inflammatory bowel disease	DD72	Phase 1	[4]

2 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AMX-256	DMGHXQE	Short bowel syndrome	KB89.1	Investigative	[5]
FE-203799	DMBX81R	Gastrointestinal disease	DE2Z	Investigative	[5]

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Poster Abstracts. Volume 10, Issue Supplement S8, pages 126-209, December 2014.
• [3] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020865)
• [4] US patent application no. 8,580,918, Peptidic glp-2 agonists.
• [5] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 250).